基于NLRP3/Caspase-1/GSDMD经典途径介导的肝实质细胞焦亡探讨活性维生素D对砷致肝纤维化损伤的干预作用及机制
批准号:
82060582
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
王大朋
依托单位:
学科分类:
地方病学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
王大朋
中文摘要
地方性砷中毒除典型皮肤损伤外尚存在不同程度肝损伤,申请人前期研究亦显示砷暴露可显著诱导体外肝星状细胞(HSC)活化及大鼠肝纤维化损伤,但其具体机制目前尚未明确,且缺乏有效治疗手段。近期报道均发现NLRP3/Caspase1/GSDMD经典途径介导的细胞焦亡可能是肝纤维化发生发展的关键分子事件,然而其是否参与砷致肝纤维损伤目前未见报道。维生素D(Vit D)是人体必需脂溶性维生素,流行病学研究显示肝纤维化患者体内普遍存在Vit D缺乏,另有研究报道Vit D可通过VDR调控NLRP3介导的细胞焦亡逆转多种疾病发生发展。然而,活性Vit D是否可拮抗砷致肝纤维化损伤,其拮抗机制是否与NLRP3介导的细胞焦亡有关目前均不清楚。本项目拟通过体内外两个层面探讨NLRP3经典途径介导的肝实质细胞焦亡在活性Vit D干预砷致肝纤维化损伤的作用及机制,为砷中毒肝损伤患者的针对性防治及营养干预提供新策略。
英文摘要
In addition to typical skin lesions, endemic arsenicosis also showed different degrees of liver injury, our previous studies also confirmed that arsenic exposure can significantly induce hepatic stellate cells (HSC) activation and liver fibrosis in rats, but its specific mechanism is not yet clear, and there is also a lack of effective treatment measure. Recent reports have found that the classical pathway of NLRP3/Caspase1/GSDMD mediated pyroptosis may be a key molecular event in the development of liver fibrosis. However, whether NLRP3 mediated pyroptosis is involved in the process of arsenic-induced liver fibrosis has not been reported yet. Vitamin D (Vit D) is an essential fat-soluble vitamin for human body, a large number of epidemiological studies have shown that Vit D deficiency is significantly related to liver fibrosis, and various studies also have reported that Vit D can reverse the occurrence and development of many diseases by regulating NLRP3-mediated pyroptosis through binding to VDR. However, it is not clear whether Vit D can antagonize arsenic-induced liver fibrosis, and whether its antagonistic mechanism is related to NLRP3-mediated pyroptosis is also unclear. On the basis of our previous studies, this project intends to systematically explore the role and mechanism of NLRP3/Caspase1/GSDMD mediated pyroptosis in the intervention effects of active Vit D on arsenic-induced liver fibrosis through both in vivo and in vitro studies, which could provide new strategies for scientific prevention and nutritional intervention of liver injury caused by endemic arsenicosis.
地方性砷中毒除典型皮肤损伤外尚存在不同程度肝损伤,申请人前期研究亦显示砷暴露可显著诱导体外肝星状细胞(HSCs)活化及大鼠肝纤维化损伤,但其具体机制目前尚未明确,且缺乏有效治疗手段。近期报道均发现NLRP3炎症小体介导的细胞焦亡可能是肝纤维化发生发展的关键分子事件,然而其是否参与砷致肝纤维损伤目前未见报道。维生素D(Vit D)是人体必需脂溶性维生素,流行病学研究显示肝纤维化患者体内普遍存在Vit D缺乏,另有研究报道Vit D可通过调控Nrf2抗氧化信号通路、TLR4炎症信号通路及NLRP3介导的细胞焦亡逆转多种疾病发生发展。然而,Vit D是否可拮抗砷致肝纤维化损伤,其拮抗机制是否与上述信号通路有关目前均不清楚。该项目通过动物、细胞两个层面从不同角度系统探讨了Vit D对砷致肝纤维化损伤中的干预作用及分子机制。研究发现:(1)长期砷暴露可导致SD大鼠肝纤维化损伤,该过程伴随着NLRP3炎症小体活化及炎性因子分泌异常;NLRP3抑制剂MCC950及活性Vit D干预可有效抑制肝组织NLRP3炎症小体活化,进而减轻砷暴露所致肝纤维化损伤;砷可诱导大鼠原代肝实质细胞(HCs)发生细胞焦亡,且NLRP3炎症小体活化参与该过程;NLRP3炎症小体介导的砷致HCs细胞焦亡可诱导HSCs进一步活化及ECM沉积。(2)活性Vit D可通过VDR进一步激活Nrf2介导的抗氧化信号通路表达,降低TLR4免疫炎症信号通路活化及其介导的炎性因子分泌水平,进而抑制HSCs活化和ECM过度沉积,改善砷诱导的肝纤维化损伤。上述系列研究结果对深入理解砷致肝纤维化损伤分子机制及Vit D对砷中毒肝损伤的干预作用及机制,以及砷中毒肝损伤的针对性营养干预均有重要科学意义及转化应用价值。
Kupffer细胞极化及胞葬作用介导肝脏不同类型细胞间串扰在维生素D拮抗砷致肝纤维化中的作用及机制研究
-
批准号:82560653
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:王大朋
-
依托单位:
基于Kupffer细胞探讨Toll样受体4介导的免疫炎症反应在砷致肝纤维化损伤中的作用及机制
-
批准号:81872657
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2018
-
负责人:王大朋
-
依托单位:
Mig-6/EGFR信号通路在砷致肝纤维化损伤中的作用及其机制研究
-
批准号:81660525
-
项目类别:地区科学基金项目
-
资助金额:45.0万元
-
批准年份:2016
-
负责人:王大朋
-
依托单位:
国内基金
海外基金